Akers Biosciences' Protein Preparation Gets Patent Cover

Akers Biosciences Inc. recently won a patent from the United States Patent and Trademark Office (USPTO) for its proprietary protein preparation. The preparation serves as the antigen and biologically active component for the Particle ImmunoFiltration (PIFA Heparin/PF4) Rapid Assay and PIFA PLUSS PF4 tests, which detect heparin-induced thrombocytopenia (HIT).